CTLA4 and neoplasm: Recently, the SLC delivery system in the safe and widely applied programmed probiotics Ecoil Niddle 1917 that constitute produced nanobody antagonist of PD-L1, CTLA-4 (33), or CD475 combined with a controllable lysing mechanism, a minimized of toxicities in tumor tissues.